Newsroom | 3846 results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that data from Study 250-902 (NCT03227042), a prospective, multicenter, multinational, noninterventional, longitudinal natural history study designed to characterize disease progression in pediatric participants with severe, non-attenua...

MEDINA, Ohio--(BUSINESS WIRE)--RPM Increases Cash Dividend for 53rd Consecutive Year...

NEW YORK--(BUSINESS WIRE)--VB Spine will showcase its xvision X2 headset and Vulcan Spinal System at the North American Spine Society’s 41st Annual Meeting....

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces ZENBEXUSTM (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates Superior......

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) today hosted its 2026 Investor Day, "Shaping the Future of Food Safety," in New York City, where the company's senior leadership team outlined a comprehensive strategy for sustained profitable growth and category leadership, and provided a framework under which it plans to achieve financial targets by fiscal year 2031. The event featured presentations from Mike Nassif, President and Chief Executive Officer; Bryan Riggsbee, Chief...

VILLEJUIF, France--(BUSINESS WIRE)--Regulatory News: Valerio Therapeutics (FR0010095596 - ALVIO), société de biotechnologie pionnière dans le domaine des thérapies de précision de nouvelle génération (« Valerio », ou la « Société »), fait un point sur son activité et présente ses résultats financiers pour le semestre clos le 30 juin 2026. « Le premier semestre 2026 a marqué une étape décisive dans la consolidation de notre recentrage stratégique et dans la transformation de Valerio Therapeutics...

VILLEJUIF, France--(BUSINESS WIRE)--Regulatory News: Valerio Therapeutics (FR0010095596 - ALVIO), a pioneering biotechnology company in the field of next-generation precision therapies (“Valerio”, or the “Company”), provides an update on its operations and presents its financial results for the half-year ended 30 June 2026. “The first half of 2026 marked a decisive milestone in the consolidation of our strategic refocusing and in the transformation of Valerio Therapeutics. The operational launc...

CINCINNATI--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE: PG) will webcast its 2026 Annual Meeting of Shareholders, held virtually via a live audio webcast on Tuesday, October 13, 2026, at 9:00 a.m. Eastern Time at: www.virtualshareholdermeeting.com/PG2026. Media and investors may access the live webcast beginning at 8:45 a.m., approximately 15 minutes before the annual meeting’s 9:00 a.m. start time. The webcast will also be available for replay. For information on meeting business...

ATLANTA--(BUSINESS WIRE)--The Annual Meeting of the HOPE Global Forums, the world’s largest gathering dedicated to economic inclusion, financial literacy and the empowerment of underserved communities, will take place December 2-3, 2026 at the Signia by Hilton in downtown, marking the 12th year that Operation HOPE’s flagship global gathering will be held in Atlanta. Atlanta Mayor Andre Dickens will return as Co-Chair of the event, continuing a longstanding partnership between Operation HOPE and...

VANCOUVER, B.C.--(BUSINESS WIRE)--Spanish Mountain Gold Ltd. (the "Company" or "Spanish Mountain Gold") (TSX-V: SPA) (FSE: S3Y) (OTCQB: SPAUF) is pleased to announce the voting results from its 2026 Annual General Meeting held in Vancouver, British Columbia, on October 1, 2026 (the “AGM”). At the AGM, a total of 123,703,643 common shares were voted, representing 23.41% of the outstanding common shares as of the record date. Shareholders elected the following directors at the AGM: Brent Bergeron...